Shuren Highlights CDRH Actions To Ease Trial Burdens On Capitol Hill
This article was originally published in The Gray Sheet
Executive Summary
CDRH Director Jeffrey Shuren participated in the first roundtable of a newly launched House Energy and Commerce Committee initiative to accelerate drug and device development. He emphasized the device center’s recent proposals to minimize pre-market data collection with postmarket controls, and supported the promise of clinical trial networks.